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Background: Autonomic imbalance, characterized by sympathetic hyperactivity and diminished vagal tone, is
a known mechanism for essential hypertension. Inspiratory muscle training (IMT) demonstrates beneﬁcial
outcomes in a number of cardiovascular populations, which may potentially extend to patients with hyper-
tension. The aim of this study was to further elucidate the effects of IMT on blood pressure and autonomic
cardiovascular control in patients with essential hypertension.
Methods: Thirteen patients with hypertensionwere randomly assigned to an eight-week IMT program (6 patients)
or to a placebo-IMT (P-IMT, 7 patients) protocol.We recordedRR interval for posterior analysis of heart rate variabil-
ity and blood pressure, by ambulatory blood pressure monitoring (ABPM), before and after the program.
Results: There was a signiﬁcant increase in inspiratory muscle strength in the IMT group (82.7±28.8 vs 121.5±
21.8 cmH2O, Pb0.001), which was not demonstrated by P-IMT (93.3±25.3 vs 106.1±25.3 cmH2O, PN0.05).
There was also a reduction in 24-hour measurement of systolic (133.2±9.9 vs 125.2±13.0 mmHg, P=0.02)
and diastolic (80.7±12.3 vs 75.2±1.0 mmHg, P=0.02) blood pressure, as well as in daytime systolic (136.8±
12.2 vs 127.6±14.2 mmHg, P=0.008) and diastolic (83.3±13.1 vs. 77.2±12.2mmHg, P=0.01) blood pressure
in the IMT group. In relation to autonomic cardiovascular control, we found increased parasympatheticmodulation
(HF: 75.5±14.6 vs. 84.74±7.55 n.u, P=0.028) and reduced sympathetic modulation (LF: 34.67±20.38 vs.
12.81±6.68 n.u; P=0.005). Moreover, there was reduction of cardiac sympathetic discharge (fLF) in IMT
group (P=0.01).
Conclusions: IMT demonstrates beneﬁcial effects on systolic and diastolic blood pressure as well as autonomic
cardiovascular control in hypertensive patients.
© 2011 Elsevier Ireland Ltd.Open access under the Elsevier OA license. 1. Introduction
Hypertension is known to be a major risk factor for cardiovascular
morbidity and mortality [1–4]. Moreover, its severity is positively re-
lated to organ damage and the development of heart, kidney and liver
failure [5]. One of the multifactorial causes of essential hypertension
is autonomic imbalance, which is primarily treated by pharmacologic
management [6].
Recently, several investigations have reported on the effects of non
pharmacologic interventions on blood pressure management in this
population [7–10]. Along these lines, previous studies have reported au-
tonomic cardiovascular control alterations with different breathingin Science of Rehabilitation —
legre, RS, Brazil. Tel.: +55 51
cspa.edu.br (P.D. Lago).
nder the Elsevier OA license. patterns [7, 10–15], implicating a ventilatory inﬂuence on hemodynam-
ics. Based on these results, one may posit that breathing exercises and
respiration control are a viable treatment option for hypertension with
a more favorable side effect proﬁle compared to pharmacology.
Findings from previous breathing exercise programs in patients
with hypertension, without an imposed external resistance or any
documented improvement in inspiratory muscle strength and/or en-
durance, suggest that the resultant reduction in respiratory rate
lowers blood pressure (BP) by favorable modulation of cardiovascular
reﬂexes [7, 11].
Inspiratory muscle training (IMT), which does impose an external
resistance to the respiratory musculature, has demonstrated beneﬁcial
training effects in patients with cardiovascular disease, speciﬁcally in
patients with chronic heart failure [16]. However, to our knowledge,
the effect of IMT in patients with essential hypertension has not been
investigated. Moreover, there appear to be no reports about its effects
on blood pressure and cardiovascular autonomic control in any cohort.
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pothesis that an eight-week program of IMTwould result in both a re-
duction in arterial blood pressure and improvement of autonomic
cardiovascular control in patients with essential hypertension.
2. Materials and methods
2.1. Study design/selection criteria
A prospective, randomized, controlled, double blinded trial was conducted in pa-
tients with a diagnosis of essential hypertension (of all stages) who were recruited
from the Ambulatory of Hypertension of Instituto de Cardiologia do Rio Grande do Sul.
The primary endpoint of this study was to evaluate the effects of IMT on blood pressure
and the secondary endpoint was to assess the impact of the intervention on autonomic
cardiovascular control variables, inspiratory muscle strength and functional capacity.
Inclusion criteria for the study were: previous Hypertension diagnosis, i.e. systolic
blood pressure (SBP) N140 mm Hg and/or diastolic blood pressure (DBP)N90 mm Hg
[5] in any stage and clinical stability with no change in medications for at least
2 months preceding the study. Exclusion criteria were: the presence of any comorbidity
(diabetes, chronic heart failure, etc), unstable angina, myocardial infarction, chronic
metabolic, orthopedic, or infectious disease; treatment with steroids, hormones, or can-
cer chemotherapy. Individuals with a previous diagnosis of pulmonary disease (forced
vital capacityb80% of predicted and/or forced expiratory volume in 1 sb70% of predicted)
[17], a history of exercise-induced asthma, and/or tobacco use were not recruited.
The protocol was approved, according to the ethical guidelines of the 1975 Decla-
ration of Helsinki, by the Committee for Ethics in Research of the Federal University of
Health Sciences of Porto Alegre (Protocol 08–447) and all subjects signed an informed
consent form.
Eligible subjects were randomly assigned in blocks, by electronic randomization
(www.randomization.com) to IMT or placebo-IMT (P-IMT) for 8 weeks. Before and
after the intervention, electrocardiogram (ECG), inspiratory muscle function, blood
pressure and functional capacity were assessed. Subjects and main investigators
were unaware of group allocation for any subject. No changes weremade to the method-
ological design throughout the study.
Methodological design was based on the determinations of CONSORT Statement,
2010 [18].
2.2. Inspiratory muscle training
The enrolled patients performed IMT or P-IMT for 30 min, 7 days per week, for 8 weeks
using the Threshold InspiratoryMuscle Training device (Threshold InspiratoryMuscle Train-
er, Healthscan Products Inc., Cedar Grove, New Jersey). During training, subjects were
instructed to maintain diaphragmatic breathing at a rate at 15 to 20 breaths/min. For the
IMT group, inspiratory load was set at 30% of maximal static inspiratory pressure (PImax),
and the training loads were adjusted weekly to maintain 30% of PImax during all protocol
period. The P-IMT group followed the same schedule, but with no inspiratory load.
2.3. Maximal static inspiratory pressure
Inspiratory muscle function testing was performed using a pressure transducer
(MVD-300, Globalmed, Porto Alegre, Brazil), connected to a system with two unidirec-
tional valves (DHD Inspiratory Muscle Trainer, Chicago, Illinois). PImax was deter-
mined in deep inspiration from residual volume against an occluded airway with a
minor air leak (2 mm). The highest pressure of six measurements (with less than 5%
difference) was used to deﬁne PImax. The measurements were performed before and
after the protocol by a blinded investigator, and weekly during treatment.
2.4. Ambulatory blood pressure monitoring (ABPM)
To assess changes in arterial blood pressure following the intervention, ABPM was
measured by a DynaMAPA® monitor (Cardios, São Paulo, Brazil), validated according
to international standards of the British Hypertension Society [19] and American Asso-
ciation for the Advancement of Medical Instrumentation (AAMI) [20]. The monitor was
programmed to take BP every 15 min during the day and every 30 min at night for
24 h, with a properly sized cuff positioned in the non-dominant arm. Each participant
received verbal and written instructions on the monitoring procedure and a diary to
record sleep periods, posture, activity status, medication use, and symptoms. A contact
number was provided for subjects to ask for advice and instructions or report any tech-
nical difﬁculty during the monitoring period. The exam was considered satisfactory
when at least 85% of the 24 hour measurements were assessed.
2.5. Heart rate variability (HRV)
Acquisition of the electrocardiogram signal was performed immediately before and
after the interventions. Measurements were taken with the subject resting comfortably
in supine position, head elevation of 30°, knees resting on a wedge and controlled breath-
ing. The breathing control was conducted bymusical sounds inwhich the respiration rate
was about 12 breaths/min (I:E=2:3). For the analysis of the heart rate variability, tempo-
ral series of RR intervals, obtained by the continuous ECG signal (sample rate — 1 kHz)registered by a Biopac MP150 system (Biopac, California, USA), were interpolated and
later submitted to spectral analysis through an auto regressivemodel developed inMatlab
language (Matlab 6.0, Mathworks Inc., USA). The spectral analysis of collected signals was
done using software capable of this type of analysis [21], allowing for the preliminary pro-
cessing of the registered signals and evaluation of all the needed parameters obtained by
the self-regressive model. The temporal series spectra of the tachogram, related to each
selected segment,were evaluatedquantitatively considering the values ofHRV and the re-
lation between the power of the components LF and HF of HRV or sympathetic–vagal bal-
ance (LF/HF). The outcome variable consisted on the analysis of HRV, performed by an
individual blinded to subject group assignment.2.6. Cardiopulmonary exercise testing
Maximal functional capacity was evaluated with an incremental exercise test, with si-
multaneous measurement of ventilatory expired gas analysis, on a cycloergometer (Inbra-
sport, Porto Alegre, Brazil). A ramp protocolwas employedwith a constant speed of 60 rpm
(rotations per minute), starting load of 25W and increments each 2 min of 15 or 25W,
depending on patients physical condition, to reach volitional fatigue at approximately
10 min. Twelve-lead electrocardiographic tracings were obtained beat-to-beat (Inbramed
APEX2000, Porto Alegre, Brazil). Bloodpressurewasmeasured every 2 minwith a standard
cuff sphygmomanometer. Metabolic and ventilatory variables were measured during and
after exercise by 20-s mean aliquots, using a computer-aided gas analyzer (VO2000 Inbra-
sport) that was calibrated prior to each test. During the test, we analyzed minute ventila-
tion (VE), oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory
exchange ratio, (VCO2/ VO2) and ventilatory equivalents for oxygen (VE/VO2) and carbon
dioxide (VE/VCO2). Based on this data, the maximal oxygen consumption (VO2máx) was
determined, as well as the ﬁrst (L1) and second (L2) ventilatory thresholds.2.7. Statistical analysis
Data were analyzed by the Statistical Package for Social Sciences (version 10.0,
SPSS, Chicago, Illinois) and tested with the Kolmogorov–Smirnov for normality. All
the variables fulﬁlled normality criteria. Descriptive data are presented as mean±SD.
Baseline and blood pressure data were compared by the Student t test for continuous
variables or by the Fisher exact test for categorical variables. Heart rate variability com-
ponents and PImax were analyzed by two-way analysis of variance for repeated measures
(ANOVA), andpost-hoc analysis was conducted by the Neuman–Keuls test. A P-valueb0.05
was considered statistically signiﬁcant for all tests.3. Results
3.1. Baseline characteristics
From July 2009 to September 2010, 168 patients with essential hy-
pertension were screened for the study. Out of those, 149 patients did
not meet the inclusion or met one or more of the exclusion criteria, and
so, 19 patients were randomized. For the 9 patients allocated in the IMT
group, 1 had a new diabetes diagnosis during the protocol, 1 had an al-
teration in pharmacologic management and 1 refused to continue the
protocol. Thus, 3 subjectswere excluded from the IMTgroup after initial
enrollment. For the 10 patients allocated to P-IMT, 1 became pregnant
at the end of the protocol and could not do the ﬁnal assessment, 1 had
a newheart failure diagnosis during theprotocol and 1had an alteration
in pharmacologic management. Therefore, 13 patients completed the
protocol, 6 patients in the IMT group and 7 patients in the P-IMT
group. Aﬂowdiagramof included, excluded and the ﬁnal number of par-
ticipants is illustrated in Fig. 1. Clinical characteristics for both groups,
baseline scores, including diastolic and systolic BP, heart rate variability
and PImax, were comparable between the two groups (Table 1).3.2. Inspiratory muscle strength
There was a signiﬁcant increase in PImax in IMT group (82.7±28.8
vs 121.5±21.8 cmH2O, Pb0.001 for time effect and P=0.003 for inter-
action effect). Conversely, the P-IMT group did not show any change in
respiratory muscle strength following treatment (93.3±25.3 vs
106.14±25.3 cmH2O, PN0.05) (Fig. 2). The IMT induced improve-
ment in PImaxwas apparent after the 5 week of training and reached
a 47% increase after 8 weeks.
Fig. 1. Flow diagram of the recruitment process and allocation of the participants.
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There was a decrease of both systolic (133.2±9.9 vs 125.2±
13.0 mmHg, P=0.02) and diastolic (80.7±12.3 vs 75.2±1.0 mm Hg,
P=0.02) blood pressure in the IMT group after training (Fig. 3A and
B). Analyzing daytime and nighttime measures separately, we found a
reduction of systolic (136.8±12.2 vs 127.6±14.2 mmHg, P=0.008)
and diastolic (83.3±13.1 vs 77.2±12.2 mmHg, P=0.01) daytime
blood pressures in the IMT group (Fig. 3C and D). However, no changes
were found in both nighttime systolic (P=0.16) and diastolicTable 1
Baseline characteristics of patients randomized to P-IMT or IMT.
IMT P-IMT
(n=6) (n=7)
Gender (male/female) 3/3 2/5
Age (yrs) 61.8±11.1 52.1±8.8
Body mass index (Kg∗m-2) 26.8±2.5 27.8±1.7





Beta blockers 66.7 57.4
Calcium antagonists 16.7 42.7
ACE inhibitors 83.3 71.4
Time of diagnosis (%)
1 to 5 years 33.3 28.6
5 to 10 years 16.7 14.4
N10 years 50.0 57.1
Values expressed as mean±standard deviation. IMT: inspiratory muscle training;
P-IMT: placebo-inspiratory muscle training; PImax : maximal static inspiratory pressure;
SBP: Systolic blood pressure; DBP: Diastolic Blood Pressure.(P=0.14) blood pressure in the IMT group. There was no change in
blood pressure in the P-IMT group.
3.4. Heart rate variability
The high frequency component (HF) increased in the IMT group
post training (75.5±14.6 vs 84.7±7.5 n.u.; P=0.028), while it did
not change in the P-IMT group (60.2±24.8 vs 53.5±17.0 n.u.;
P=0.37). Comparing the effect between groups, IMT was favorable in
relation to placebo (P=0.009) for this component of heart rate variabil-
ity analysis. Additionally, there was a reduction in the low frequency
component (LF) in the IMT group (34.6±20.3 vs 12.8±6.6 n.u.;
P=0.005) but not in the P-IMT group (39.7±24.8 vs 46.5±17.0;
P=0.38). Further, analyzing the results pertaining to the low frequencyFig. 2. Inspiratory muscle strength. Weekly values of maximal inspiratory pressure
(PImax, mean±SD) for placebo-inspiratory muscle training (P-IMT) and inspiratory
muscle training (IMT) groups. *Two-way ANOVA for repeated measures: pb0.01 for
time effect, signiﬁcantly different from base line evaluation by the Neuman–Keuls test.
Fig. 3. Systolic and diastolic blood pressure changes. Evaluation of ABPM blood pressure changes before and after inspiratory muscle training in the treatment (IMT) and placebo (P-IMT)
groups. A: Changes of 24-hour systolic bloodpressure (SBP,mean±SD). B: Changes of 24-hour diastolic bloodpressure (DBP,mean±SD). C:Changes of Daytime SBP,mean±SD.D: Changes
of daytime DBP, mean±SD. * Student t Test: pb0.05 for time effect, signiﬁcant difference from baseline.
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compared to P-IMT (P=0.01). There was also a difference comparing
IMT to P-IMT after training for the fLF component (P=0.013), demon-
strating favorable modiﬁcations in sympathetic discharge in IMT
group. Results of the spectral analysis are shown in Table 2 and Fig. 4.
3.5. Cardiopulmonary exercise testing
Comparison of the peak respiratory exchange revealed no signiﬁ-
cant differences between the baseline and post training CPX in either
the IMT (1.1±04 vs 1.0±0.06, PN0.05) or P-IMT (1.1±0.1 vs 1.1±0.06,
PN0.05) group, indicating comparable effort. The samewas observed for
peak systolic blood pressure in the IMT (183.3±24.2 vs. 186.7±Table 2
Spectral analysis of heart rate variability components before and after IMT and P-IMT.
IMT (n=6) P-IMT (n=7)
Before After Before After
HR (bpm) 61.3±12.7 61.3±14.8 71.0±14.7 73.3±10.2
HRV components
var (ms2) 0.6±0.3 0.7±0.5 1.2±1.3 0.6±0.5
fLF (Hz) 0.06±0.02 0.08±0.03 0.07±0.03 0.04±0.01‡
LF (ms2) 203.6±169.7 72.9±33.2 334.2±497.3 170.9±136.5
LF (n.u.) 34.7±20.3 12.8±6.7⁎ 39.8±24.9 46.5±17.1‡
fHF (Hz) 0.2±0.003 0.2±0.01 0.2±0.02 0.2±0.01
HF (ms2) 375.6±257.9 563.7±245.7 1064.6±1769.4 339.8±436.7
HF (n.u.) 75.5±14.6 84.7±7.5⁎ 60.2±24.9 53.5±17.1‡
LF/HF 0.7±0.7 0.16±0.09 1.11±1.4 1.10±0.9
The values are expressed as mean±SD. Two-way ANOVA for repeated measures. Heart
Rate=HR; HRV=Heart rate variability; VLF=very low frequency component;
LF=low frequency component; HF=high frequency component.
⁎ Pb0.05 for training and interaction effects.
‡ Pb0.05 for group effect.25.0 mmHg, PN0.05) and P-IMT (208.3±29.1 vs. 197.5±30.9 mmHg,
PN0.05) groups. In relation to oxygen uptake, peak VO2 was not sig-
niﬁcantly different after the protocol in either the IMT (19.0±3.8
vs. 23.9±13.6 mlO2∗kg−1∗min−1, PN0.05) or P-IMT (17.2±3.2 vs.
18.8±6.8 mlO2∗kg−1∗min−1, PN0.05) group.
4. Discussion
To our knowledge, this is the ﬁrst controlled blinded trial evaluating
the effects of IMT in patients with essential hypertension. In this study,
we demonstrated that a home-based, eight-week IMT program reduced
daytime systolic (−7.9 mmHg) and diastolic (−5.5 mmHg) blood
pressure and improved cardiovascular autonomic control, which is re-
lated to cardiovascular risk factors, by reducing sympathetic modula-
tion (LF n.u. component) and increasing parasympathetic modulation
(HF n.u. component), in patients with essential hypertension. The efﬁ-
cacy of IMT was compared to a placebo intervention, and all outcomes
were blindly evaluated. As none of the patients had never done IMT be-
fore, according to previous interview, and the practice of IMT with low
load has been studied before with no side effects [22], we considered
that all participants were blinded according to both load and the place-
bo effect. Compliance was evaluated by the use of a training diary,
where all participants documented their daily practice and also by
weekly interviews conducted by the samephysician. Thuswe are highly
conﬁdent subjects were compliant with the home-based intervention.
4.1. Inspiratory muscle training
Many studies have demonstrated a clinically important gain in in-
spiratory muscle strength and endurance after IMT, especially in co-
horts diagnosed with chronic heart failure and chronic obstructive
pulmonary disease [16, 23–25]. In the present study, patients in the
IMT group had a 47% increase in inspiratory muscle strength after
Fig. 4. An example of spectrum of Heart Rate Variability (HRV). The graphic shows power spectrum of the RR interval series: the frequency, expressed in Hz, is reported on the
x-axis, while the power spectral density of HRV, expressed in s2/Hz is reported on the y-axis. Dashed line represents P-IMT group and solid line represents IMT group. The pie graph-
ic on the right represents the Total Heart Rate Variability divided into the two components, in percentages of total, LF [P-IMT (gray) and IMT (black)] and HF (white). A: spectrum of
HRV before treatment. B: spectrum of HRV after treatment.
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Dall'Ago et al [16], patients with chronic heart failure demonstrated
an increase of 115% in PImax after 12 weeks of treatment. While im-
provements in both trials were statistically signiﬁcant compared to
baseline, the dramatically greater improvement in patients with heart
failure is likely due to the fact that patients diagnosed with this chronic
condition have far worse respiratory muscle function at baseline (i.e.
greater potential for improvement).
Thus, IMT improved BP and autonomic tone without improving
aerobic capacity in the current investigation. This is different from
what has been found in heart failure [16, 22]. A hypothesized reason
for this lack of change in aerobic capacity in the present study is that sub-
jects were far less functionally disabled compared to subjects diagnosed
with heart failure. Therefore, IMT was not enough to improve total body
aerobic function. Patients with chronic heart failure have a much lower
total body aerobic capacity and thus IMT appears to be a sufﬁcient stim-
ulus to induce a signiﬁcant increase in peak VO2. Even so, the other pos-
itive physiologic adaptations reported in the current study potentially
justify the use of IMT in patients with essential hypertension and well
preserved aerobic function.
4.2. Effects of IMT on blood pressure
The current study demonstrated that an 8 week IMT programwith
a 30% PImax load was able to reduce daytime arterial blood pressure.
Other studies have reported similar results with the practice of
breathing exercises, without load [7, 10–11, 13, 15] in cohorts with
similar characteristics to the one examined in the current analysis.
Respiratory modulation is related to cardiovascular modulation and
it plays a pivotal role in blood pressure control. This important interac-
tivity is noticed by the generalized alteration that occurs in cardiovascu-
lar control in conjunction with respiratory pattern modiﬁcations. This
relationship is likely related to baroreceptor and chemoreceptor sensi-
tivity [26] interaction and its inﬂuence on the mechanisms of blood
pressure control. In a certain manner, reductions of blood pressure are
more evidencedwith the practice of slow breathing [10–13]when com-
pared to a faster respiratory pattern [15]. However, subjects included in
the present study did not control respiratory rate during IMT sessions orduring blood pressure assessment. Therefore, the present results suggest
that modiﬁcations in blood pressure level are at least in part, related to
the inspiratory load used during IMT (represented by the use of inspira-
tory load) and thus not only associatedwith alterations in the respiratory
pattern as previously reported [7, 12, 15, 27–28].
The mean reduction in systolic and diastolic blood pressure found
in the current study was higher than the found by others examining
the effects of slow breathing exercise [7–8, 29]. However, the majority
of the studies that report changes in BP after breathing exercises did
not perform ABPM, as we did. Comparing our results with those pre-
sented by Modesti et al [8], when the effects of slow breathing were
evaluated with AMBP, our data demonstrated a better outcome in
both systolic (−7.9 vs −5.4 mmHg) and diastolic (−5.5 vs
−2.4 mmHg) BP reduction. This comparison suggests that inspiratory
load promotes more beneﬁcial effects on blood pressure control in hy-
pertensive subjects compared to breathing exercises.
4.3. Effects of IMT on autonomic cardiovascular control
Slow breathing leads to RR ﬂuctuations, which are related to blood
pressure changes mediated by respiratory modulation and with en-
hanced baroreﬂex activity [11]. We did not evaluate baroreﬂex activ-
ity in the current study, although it is well established that both
baroreﬂex [11, 28] and chemoreﬂex [27] sensitivity among the mech-
anisms involved in sympathetic modulation. So, it seems reasonable to
hypothesize that besides the reduction of sympathetic activity that we
have found here, there would also be some positive effect on baroreﬂex
and/or chemoreﬂex sensitivity.
Moreover, induction of inspiratory muscle fatigue in healthy
humans results in an increase of muscle sympathetic nerve activity,
heart rate and mean arterial pressure [14], and a gradual reduction
in arterial blood ﬂow to the resting limbs [30]. Therefore, experimental
research shows that a fatiguing diaphragm leads to increased sympathet-
ic outﬂow [31]. These previous observations collectively suggest that in-
spiratory muscle fatigue generates an increase in the metaboreﬂex,
which increases peripheral sympathetic activity. Thus, enhancement of
respiratory muscle function by IMT may increase fatigue resistance and
lessen sympathetic outﬂow.
66 J.B. Ferreira et al. / International Journal of Cardiology 166 (2013) 61–67Although the RR variability was not different, it shows a behavior
close to that demonstrated by others (1998), i.e. IMT decreases the RR
interval and P-IMT increases the RR interval.
We also observed an increased parasympathetic modulation after
IMT compared to P-IMT. Although previous research in this area is lim-
ited, the current ﬁndings agree with other studies regarding the effects
of breathing exercises in patientswith hypertension. It is known that re-
spiratory patterns change autonomic cardiovascular modulation, espe-
cially with respect to the HF component of HRV [32]. Comparing the
effects of slow and fast breathing on sympathetic/parasympathetic
modulation in hypertensive subjects, Mourya et al [15] reported an im-
provement in parasympathetic activity after slow breathing.4.4. Limitations
The present study does have limitations that warrant discussion.
Firstly, sympathetic/parasympathetic system evaluation is different
among the studies we found; i.e, the method we have chosen is not
a direct measurement of autonomic modulation compared to assess-
ment of muscle sympathetic nerve activity used by others [14]. These
methodological differences may complicate the comparison of results
from different investigations in this area. Secondly, we did not perform
baroreﬂex and/or chemoreﬂex evaluation, which could be used to fur-
ther elucidate the mechanism for blood pressure reductions through
IMT. Moreover, we did not evaluate inspiratory muscle endurance;
this measurement could demonstrate training effects with more accu-
racy compared to quantiﬁcation of inspiratory muscle strength alone.
Finally, even with a small sample size, our data showed a power of
95%, analyzing the effects of IMT on autonomic cardiovascular control
between groups.
In conclusion, regarding the effects of IMT on blood pressure con-
trol in patients with essential hypertension, we found a decrease of
sympathetic and an increase of parasympathetic modulation. In addi-
tion, daytime systolic and diastolic blood pressure levels showed im-
provements only in the IMT group. These data support the assertion
that IMT is beneﬁcial in the treatment of patients with controlled hy-
pertension. Moreover, our results suggest for the ﬁrst time that a
home-based, eight-week IMT program provides important effects on
cardiopulmonary interaction, resulting in improvement in cardiovas-
cular autonomic control and blood pressure levels. The results of the
current study highlight the importance of continuing research in this
area to better elucidate the effects of IMT on this and other patient
populations and ultimately broaden appropriate clinical application.4.5. Perspectives
IMT may be a possible non pharmacological treatment option for
patients with hypertension. In addition to positive physiologic adapta-
tions, beneﬁts of this approach include cost efﬁciency, home-based
therapy, and minimal exertional requirements. Moreover, we intend
to investigate other effects in the future, such as a reduction in the
need for pharmacological treatment, especially beta-blocker use, and
the impact in the quality of life in these patients.
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